← The Wire
ALMSNasdaq
ALUMIS INC.
Pharmaceutical Preparations · DE · CIK 1847367
Develop targeted therapies for immune-mediated diseases using precision data analytics and biological insights
$3.08B
Market cap
$27.14
Last close
+2.8%
1D
+10.3%
5D
1.7M
Volume
Price · last 39 sessions+7.5%
May 4L $18.99 · H $27.14Jun 29
69
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KCompany UpdateJun 29, 2026DEFA14ADEFA14AMay 18, 2026DEF 14ADEF 14AMay 18, 202610-Q10-QMay 14, 20268-KResults of OperationsMay 14, 2026SC 13D/ASC 13D/AApr 3, 20268-KCompany UpdateMar 30, 202610-K10-KMar 19, 20268-KResults of OperationsMar 19, 2026SC 13D/ASC 13D/AJan 13, 2026SC 13D/ASC 13D/AJan 12, 20268-KResults of Operations · Company UpdateJan 9, 2026424B5424B5Jan 8, 2026424B5424B5Jan 6, 20268-KCompany UpdateJan 6, 20268-KCompany UpdateJan 2, 202610-Q10-QNov 13, 20258-KResults of OperationsNov 13, 20258-KCompany UpdateSep 3, 202510-Q10-QAug 13, 20258-KResults of OperationsAug 13, 20258-KShareholder VoteAug 4, 20258-K/ACompany UpdateJun 30, 2025DEFA14ADEFA14AJun 16, 2025DEF 14ADEF 14AJun 16, 20258-KExecutive Change · Acquisition / DispositionMay 21, 20258-KShareholder VoteMay 19, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 14, 2025425425Apr 29, 202510-K/A10-K/AApr 23, 2025S-4FORM S-4Apr 21, 2025425425Apr 21, 2025425425Apr 21, 2025425425Apr 21, 20258-KMaterial Agreement · Company UpdateApr 21, 2025425425Apr 4, 2025S-4FORM S-4Mar 27, 2025425425Mar 25, 20258-KCompany UpdateMar 25, 2025425425Mar 19, 202510-K10-KMar 19, 20258-KResults of OperationsMar 19, 20258-KCompany UpdateMar 18, 2025425425Mar 18, 2025425425Mar 11, 20258-KCompany UpdateMar 10, 2025425425Mar 6, 2025425425Mar 4, 20258-KReg FD DisclosureMar 4, 20258-KExecutive ChangeFeb 21, 2025425425Feb 7, 2025425425Feb 7, 2025425425Feb 6, 2025425425Feb 6, 20258-KMaterial Agreement · Results of OperationsFeb 6, 20258-KCompany UpdateNov 25, 202410-Q10-QNov 13, 20248-KResults of OperationsNov 13, 2024SC 13DSC 13DAug 27, 202410-Q10-QAug 13, 20248-KResults of OperationsAug 13, 20248-KCompany UpdateJul 18, 2024SC 13GSC 13GJul 11, 2024SC 13DSC 13DJul 5, 2024SC 13DALUMIS INC.Jul 3, 20248-KMaterial Agreement · Equity IssuanceJul 3, 20248-KBylaw AmendmentJul 1, 2024424B4424B4Jun 28, 2024S-1/AS-1/AJun 24, 2024S-1/AS-1/AJun 18, 2024S-1S-1Jun 7, 2024
Insider Activity
◆ Cluster Buy · 6 insidersIn the 90 days to Jan 9, 2026: 6 insiders bought $51.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 9, 2026 | Akkaraju SrinivasDirector | Buy | 588,235 | $17.00 | $10.0M |
| Jan 8, 2026 | Foresite Labs Fund I, L.P.TenPercentOwner | Buy | 294,117 | $17.00 | $5.0M |
| Jan 8, 2026 | Tananbaum James B.Director,TenPercentOwner | Buy | 294,117 | $17.00 | $5.0M |
| Jan 8, 2026 | Foresite Labs, LlcTenPercentOwner | Buy | 294,117 | $17.00 | $5.0M |
| Jan 8, 2026 | Foresite Labs, LlcTenPercentOwner | Buy | 117,647 | $17.00 | $2.0M |
| Jan 8, 2026 | Foresite Labs Fund I, L.P.TenPercentOwner | Buy | 117,647 | $17.00 | $2.0M |
| Jan 8, 2026 | Tananbaum James B.Director,TenPercentOwner | Buy | 117,647 | $17.00 | $2.0M |
| Dec 5, 2025 | Akkaraju SrinivasDirector | Buy | 70,028 | $10.01 | $701K |
| Dec 5, 2025 | Akkaraju SrinivasDirector | Buy | 64,969 | $8.95 | $581K |
| Dec 5, 2025 | Akkaraju SrinivasDirector | Buy | 51,380 | $10.73 | $551K |
| Dec 4, 2025 | Akkaraju SrinivasDirector | Buy | 66,027 | $8.18 | $540K |
| Dec 3, 2025 | Akkaraju SrinivasDirector | Buy | 100,000 | $7.75 | $775K |
| Dec 2, 2025 | Akkaraju SrinivasDirector | Buy | 96,000 | $7.55 | $725K |
| Dec 1, 2025 | Akkaraju SrinivasDirector | Buy | 86,350 | $7.46 | $644K |
| Nov 28, 2025 | Akkaraju SrinivasDirector | Buy | 38,702 | $7.64 | $296K |
| Nov 26, 2025 | Akkaraju SrinivasDirector | Buy | 48,537 | $7.64 | $371K |
| Nov 21, 2025 | Foresite Labs Affiliates 2021, LlcTenPercentOwner | Buy | 72,212 | $7.38 | $533K |
| Nov 21, 2025 | Foresite Labs Fund I, L.P.TenPercentOwner | Buy | 72,212 | $7.38 | $533K |
| Nov 21, 2025 | Tananbaum James B.Director,TenPercentOwner | Buy | 72,212 | $7.38 | $533K |
| Nov 20, 2025 | Akkaraju SrinivasDirector | Buy | 125,743 | $7.20 | $905K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance